Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Research Article

Preparation and Characterization of Multicomponent Particles for Controlled and Tunable Release of Citicoline

Author(s): Sayani Bhattacharyya* and Anisha Verma

Volume 12, Issue 3, 2022

Published on: 27 July, 2022

Page: [215 - 226] Pages: 12

DOI: 10.2174/2210303112666220620093106

Price: $65

Abstract

Background: Memory disorders require a steady-state balance of choline and cytidine. Citicoline is prescribed as an exogenous source of choline and cytidine.

Objective: The present study proposes a mucoadhesive multiparticulate sustained delivery of citicoline as a supportive control for memory loss.

Methods: The formulation of citicoline sodium microparticles was done by ionotropic gelation method using alginate and hydroxypropyl methylcellulose (HPMC) in three different ratios. The three formulations were preliminary evaluated for the in vitro drug release study. Depending on their release pattern, a simplex lattice mixture design of 21 trial runs, with a set of possible combinations of each component of the three formulations, was employed to get an optimized ratio that could attend a predetermined release of drug at 1st, 4th, 6th, and 8th h. The optimized product was characterized for physicochemical evaluation, thermal analysis, in vitro drug release, surface morphology, and stability study.

Results: Optimization of the design yielded a ratio that could prolong the release as predicted by design. The release mechanism followed non-Fickian diffusion. Differential thermal analysis exhibited high drug entrapment in the microparticles. Surface morphology studies revealed that drug release took place by the formation of channels. Stability studies indicated there was no change in the properties even after six months and the moisture retention was meagre.

Conclusion: The employed simplex lattice design could be successfully used to make microparticles of predetermined release characteristics with a steady-state release of the drug and can be a promising approach to provide an affordable therapy of citicoline to improve its effectivity.

Keywords: Citicoline sodium, microparticles, mucoadhesive microparticles, sustained release, choline, Alz-heimer's disease.

« Previous
Graphical Abstract

[1]
Grieb, P. Citicoline: A food that may improve memory. Med. Sci. Rev., 2015, 2, 67-72.
[http://dx.doi.org/10.12659/MSRev.894711]
[2]
Miller, E. Short-and long-term memory in patients with presenile dementia (Alzheimer’s disease). Psychol. Med., 1973, 3(2), 221-224.
[http://dx.doi.org/10.1017/S003329170004856X] [PMID: 4715855]
[3]
Synoradzki, K.; Grieb, P. Citicoline: A superior form of choline? Nutrients, 2019, 11(7), E1569.
[http://dx.doi.org/10.3390/nu11071569] [PMID: 31336819]
[4]
Secades, J.J. Citicoline in the treatment of cognitive impairment. J. Neurol. Exp. Neurosci., 2019, 05(01), 88-100.
[http://dx.doi.org/10.17756/jnen.2019-047]
[5]
Galletti, P.; De Rosa, M.; Cotticelli, M.G.; Morana, A.; Vaccaro, R.; Zappia, V. Biochemical rationale for the use of CDPcholine in traumatic brain injury: Pharmacokinetics of the orally administered drug. J. Neurol. Sci., 1991, 103(Suppl.), S19-S25.
[http://dx.doi.org/10.1016/0022-510X(91)90004-Q] [PMID: 1940961]
[6]
Gareri, P.; Castagna, A.; Cotroneo, A.M.; Putignano, S.; De Sarro, G.; Bruni, A.C. The role of citico-line in cognitive impairment: Pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clin. Interv. Aging, 2015, 10, 1421-1429.
[http://dx.doi.org/10.2147/CIA.S87886] [PMID: 26366063]
[7]
Grieb, P. Neuroprotective properties of citicoline: Facts, doubts and unresolved issues. CNS Drugs, 2014, 28(3), 185-193.
[http://dx.doi.org/10.1007/s40263-014-0144-8] [PMID: 24504829]
[8]
Di Mizio, G.; Marcianò, G.; Palleria, C.; Muraca, L.; Rania, V.; Roberti, R.; Spaziano, G.; Piscopo, A.; Ciconte, V.; Di Nunno, N.; Esposito, M.; Viola, P.; Pisani, D.; De Sarro, G.; Raffi, M.; Piras, A.; Chi-arella, G.; Gallelli, L. Drug-Drug interactions in vestibular diseases, clinical problems, and medico-legal implications. Int. J. Environ. Res. Public Health, 2021, 18(24), 12936.
[http://dx.doi.org/10.3390/ijerph182412936] [PMID: 34948545]
[9]
Cho, E.; Zeisel, S.H.; Jacques, P.; Selhub, J.; Dougherty, L.; Colditz, G.A.; Willett, W.C. Dietary cho-line and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am. J. Clin. Nutr., 2006, 83(4), 905-911.
[http://dx.doi.org/10.1093/ajcn/83.4.905] [PMID: 16600945]
[10]
Bansal, H.; Preet, K.S.; Gupta, A.K. Microsphere: Methods of prepration and applications; A compar-ative study. Int. J. Pharm. Sci. Rev. Res., 2011, 10(1), 69-78.
[11]
Rayakwar, N.; Dangi, Y.S. Development and characterization of controlled release bilayered tablets of Citicoline sodium. J. Drug Deliv. Ther., 2019, 9(2-s), 125-131.
[12]
Abdalla, K.F.; Kamoun, E.A.; El Maghraby, G.M. Optimization of the entrapment efficiency and re-lease of ambroxol hydrochloride alginate beads. J. Appl. Pharm. Sci., 2015, 5(4), 13-19.
[http://dx.doi.org/10.7324/JAPS.2015.50403]
[13]
Chuang, J.J.; Huang, Y.Y.; Lo, S.H.; Hsu, T.F.; Huang, W.Y.; Huang, S.L.; Lin, Y.S. Effects of pH on the shape of alginate particles and its release behavior. Int. J. Polym. Sci., 2017.
[http://dx.doi.org/10.1155/2017/3902704]
[14]
Bhattacharyya, S.; Ray, S.; Gupta, B.K.; Ghosh, L.K. Design, evaluation and statistical optimisation of a controlled release multiparticulate acyclovir delivery system. Lat. Am. J. Pharm., 2007, 26(6), 852-858.
[15]
Rajendran, A.; Basu, S.K. Alginate-chitosan particulate system for sustained release of nimodipine. Trop. J. Pharm. Res., 2009, 8(5), 433-440.
[http://dx.doi.org/10.4314/tjpr.v8i5.48087]
[16]
Pan, X.M.; Li, J.; Gan, R.; Hu, X.N. Preparation and in vitro evaluation of enteric-coated tablets of rosiglitazone sodium. Saudi Pharm. J., 2015, 23(5), 581-586.
[http://dx.doi.org/10.1016/j.jsps.2015.02.018] [PMID: 26594126]
[17]
Ryakala, H.; Dineshmohan, S.; Ramesh, A.; Gupta, V.R.M. Formulation and in vitro evaluation of bilayer tablets of nebivolol hydrochloride and nateglinide for the treatment of diabetes and hyperten-sion. J. Drug Deliv., 2015, 2015, 827859.
[http://dx.doi.org/10.1155/2015/827859] [PMID: 25648606]
[18]
Pasparakis, G.; Bouropoulos, N. Swelling studies and in vitro release of verapamil from calcium algi-nate and calcium alginate-chitosan beads. Int. J. Pharm., 2006, 323(1-2), 34-42.
[http://dx.doi.org/10.1016/j.ijpharm.2006.05.054] [PMID: 16828245]
[19]
Kavya, H.R.; Bhattacharyya, S. Statistical optimization and evaluation of a multi release unit bilayer tablet of rizatriptan benzoate. Indian J. Pharm. Sci., 2021, 83(1), 52-59.
[20]
González-Rodríguez, M.L.; Holgado, M.A.; Sánchez-Lafuente, C.; Rabasco, A.M.; Fini, A. Algi-nate/chitosan particulate systems for sodium diclofenac release. Int. J. Pharm., 2002, 232(1-2), 225-234.
[http://dx.doi.org/10.1016/S0378-5173(01)00915-2] [PMID: 11790506]
[21]
Hiremath, P.; Nuguru, K.; Agrahari, V. Material Attributes and Their Impact on Wet Granulation Pro-cess Performance; Elsevier Inc., 2019.
[http://dx.doi.org/10.1016/B978-0-12-810460-6.00012-9]
[22]
The United States Pharmacopeia, 2020.
[23]
Mohan Kamila, M.; Mondal, N.; Kanta Ghosh, L.; Kumar Gupta, B. Multiunit floating drug delivery system of rosiglitazone maleate: Development, characterization, statistical optimization of drug release and in vivo evaluation. AAPS PharmSciTech, 2009, 10(3), 887-899.
[http://dx.doi.org/10.1208/s12249-009-9276-4] [PMID: 19572199]
[24]
Ghosal, K.; Ray, S.D. Alginate/hydrophobic HPMC (60M) particulate systems: New matrix for site-specific and controlled drug delivery. Braz. J. Pharm. Sci., 2011, 47(4), 833-844.
[http://dx.doi.org/10.1590/S1984-82502011000400021]
[25]
Y, S.R.; Dinakar, A.; Srinivas, L. Design development and evaluation of citicoline controlled release tablets. Sch. Res. Libr., 2013, 5(1), 296-311.
[26]
Huang, J.; Wigent, R.J.; Schwartz, J.B. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. J. Pharm. Sci., 2008, 97(1), 251-262.
[http://dx.doi.org/10.1002/jps.21072] [PMID: 17724668]
[27]
Yu, Z.; Rogers, T.L.; Hu, J.; Johnston, K.P.; Williams, R.O., III Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid. Eur. J. Pharm. Biopharm., 2002, 54(2), 221-228.
[http://dx.doi.org/10.1016/S0939-6411(02)00050-4] [PMID: 12191695]
[28]
ICH Q1A(R2) Stability Testing of New Drug Substances and Products 2003.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy